4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: June 8, 2020
Period of Report: June 7, 2020
Accession Number: 0001104659-20-070906

View Document ↗ View on SEC.gov ↗